CD8A and clinically amyopathic dermatomyositis: Although it remains controversial whether the BAL lymphocyte subset is useful for clinical diagnosis of ILD, Suda et al. reported a higher CD4+/CD8+ ratio in patients with acute/subacute CADM-ILD than chronic CADM-ILD [23].